Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2014, Article ID 705290, 7 pages
http://dx.doi.org/10.1155/2014/705290
Research Article

Therapy with Interleukin-22 Alleviates Hepatic Injury and Hemostasis Dysregulation in Rat Model of Acute Liver Failure

Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, P.O. Box 7607, Makkah 7152, Saudi Arabia

Received 8 January 2014; Accepted 4 March 2014; Published 1 April 2014

Academic Editor: Myriam Labopin

Copyright © 2014 Tariq Helal Ashour. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. M. Lee, “Acute liver failure,” Seminars in Respiratory and Critical Care Medicine, vol. 33, pp. 36–45, 2012. View at Google Scholar
  2. F. Wu, M. Wang, and D. Tian, “Serum from patients with hepatitis E virus-related acute liver failure induces human liver cell apoptosis,” Experimental and Therapeutic Medicine, vol. 7, no. 1, pp. 300–304, 2014. View at Google Scholar
  3. P. L. Simonian, F. Wehrmann, C. L. Roark, W. K. Born, R. L. O'Brien, and A. P. Fontenot, “γδ T cells protect against lung fibrosis via IL-22,” Journal of Experimental Medicine, vol. 207, no. 10, pp. 2239–2253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. P. W. Wu, J. Li, S. R. Kodangattil et al., “IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22,” Journal of Molecular Biology, vol. 382, no. 5, pp. 1168–1183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Kumar, K. Rajasekaran, J. M. Palmer, M. S. Thakar, and S. Malarkannan, “IL-22: an evolutionary missing-link authenticating the role of the immune system in tissue regeneration,” Journal of Cancer, vol. 4, no. 1, pp. 57–65, 2013. View at Google Scholar
  6. L. A. Zenewicz and R. A. Flavell, “Recent advances in IL-22 biology,” International Immunology, vol. 23, no. 3, pp. 159–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Ren, B. Hu, and L. M. Colletti, “IL-22 is involved in liver regeneration after hepatectomy,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 298, no. 1, pp. G74–G80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. W.-W. Xing, M.-J. Zou, S. Liu, T. Xu, J.-X. Wang, and D.-G. Xu, “Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice,” Bioscience, Biotechnology and Biochemistry, vol. 75, no. 7, pp. 1290–1294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Kong, D. Feng, H. Wang et al., “Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis,” Hepatology, vol. 56, no. 3, pp. 1150–1159, 2012. View at Google Scholar
  10. D. Feng, X. Kong, H. Weng et al., “Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic HBV infection,” Gastroenterology, vol. 143, no. 1, pp. 188.e7–198.e7, 2012. View at Google Scholar
  11. X. Xiang, H. Gui, N. J. King et al., “IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver,” Immunology and Cell Biology, vol. 90, pp. 611–619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Kong, D. Feng, S. Mathews, and B. Gao, “Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease,” Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 56–60, 2013. View at Google Scholar
  13. Institute of Laboratory Animal Resources, Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC, USA, 7th edition, 1996.
  14. L.-M. Liu, J.-X. Zhang, J. Luo et al., “A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in D-galactosamine (D-GalN)-sensitized rats,” Digestive Diseases and Sciences, vol. 53, no. 5, pp. 1316–1324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Lemini, R. Jaimez, and Y. Franco, “Gender and inter-species influence on coagulation tests of rats and mice,” Thrombosis Research, vol. 120, no. 3, pp. 415–419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. D.-W. Han, “Intestinal endotoxemia as a pathogenetic mechanism in liver failure,” World Journal of Gastroenterology, vol. 8, no. 6, pp. 961–965, 2002. View at Google Scholar · View at Scopus
  17. L. Dong, L. Zuo, S. Xia et al., “Reduction of liver tumor necrosis factor-α expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis,” Journal of Gene Medicine, vol. 11, no. 3, pp. 229–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Sass, S. Heinlein, A. Agli, R. Bang, J. Schümann, and G. Tiegs, “Cytokine expression in three mouse models of experimental hepatitis,” Cytokine, vol. 19, no. 3, pp. 115–120, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. A. A. Korish, “Effect of caffeic acid phenethyl ester on the hemostatic alterations associated with toxic-induced acute liver failure,” Blood Coagulation and Fibrinolysis, vol. 21, no. 2, pp. 158–163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Pan, F. Hong, S. Radaeva, and B. Gao, “Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3,” Cellular & Molecular Immunology, vol. 1, no. 1, pp. 43–49, 2004. View at Google Scholar · View at Scopus
  21. S. Radaeva, R. Sun, H.-N. Pan, F. Hong, and B. Gao, “Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation,” Hepatology, vol. 39, no. 5, pp. 1332–1342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Yang, Y. Zhang, L. Wang et al., “Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22,” Journal of Hepatology, vol. 53, no. 2, pp. 339–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. C. Liang, C. Nickerson-Nutter, D. D. Pittman et al., “IL-22 induces an acute-phase response,” Journal of Immunology, vol. 185, no. 9, pp. 5531–5538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Wu, X. Kong, T. Zhang, J. Ye, Z. Fang, and X. Yang, “Pseudoephedrine/ephedrine shows potent anti-inflammatory activity against TNF-alpha-mediated acute liver failure induced by lipopolysaccharide/d-galactosamine,” European Journal of Pharmacology, vol. 724, pp. 112–121, 2014. View at Google Scholar
  25. A. Waage, “Presence and involvement of TNF-alpha in septic shock,” in Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, B. Beutler, Ed., pp. 275–283, Raven Press, New York, NY, USA, 1993. View at Google Scholar
  26. H. Jaeschke, G. J. Gores, A. I. Cederbaum, J. A. Hinson, D. Pessayre, and J. J. Lemasters, “Mechanisms of hepatotoxicity,” Toxicological Sciences, vol. 65, no. 2, pp. 166–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Dejager and C. Libert, “Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in d-galactosamine-sensitized mice,” Cytokine, vol. 42, no. 1, pp. 55–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Chang, H. Hanawa, H. Liu et al., “Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats,” Journal of Immunology, vol. 177, no. 6, pp. 3635–3643, 2006. View at Google Scholar · View at Scopus
  29. Y.-J. Kang, B. A. Wingerd, T. Arakawa, and W. L. Smith, “Cyclooxygenase-2 gene transcription in a macrophage model of inflammation,” Journal of Immunology, vol. 177, no. 11, pp. 8111–8122, 2006. View at Google Scholar · View at Scopus
  30. P. E. Ganey, Y.-W. Barton, S. Kinser, R. A. Sneed, C. C. Barton, and R. A. Roth, “Involvement of cyclooxygenase-2 in the potentiation of allyl alcohol-induced liver injury by bacterial lipopolysaccharide,” Toxicology and Applied Pharmacology, vol. 174, no. 2, pp. 113–121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Han, G. Li, K. Lim, M. C. DeFrances, C. R. Gandhi, and T. Wu, “Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure,” Journal of Immunology, vol. 181, no. 11, pp. 8027–8035, 2008. View at Google Scholar · View at Scopus